SCLC - Network of Cancer Research

Serplulimab (HLX 10) is humanized monoclonal anti-PD-1 antibody

Louis Gilman November 12, 2022

PD-1 (Programmed cell death protein 1; CD279) is an immune checkpoint. PD-1 is a cell surface receptor that belongs to the immunoglobulin superfamily. Besides, It shows a role in regulating…

Acute Myeloid Leukemia Lung Cancer Small Cell Lung Cancer

CC-90011 is a Selective and Orally Active Inhibitor of LSD1

Louis Gilman June 5, 2021

Lysine-specific histone demethylase 1 (LSD1) (also known as KDM1) is a member of a broad family of monoamine oxidases and is encoded by the KDM1A gene. However, LSD1 requires the…

Breast Cancer

Serplulimab (HLX 10) is humanized monoclonal anti-PD-1 antibody

CC-90011 is a Selective and Orally Active Inhibitor of LSD1

You Missed

BI 7446 is a STING Agonist for Immuno-oncology Research

JNJ-38877605 is an Orally Active c-Met Inhibitor for Solid Tumour Research

OATD-02 is an Orally Active Arginase 1/2 Inhibitor for Melanoma Research

INCB086550 is an Orally Active PD-L1 Inhibitor for Multiple Cancers Research